Muscle Pharm Corporation (OTC:MSLP) has been on the progressive move for two days already. The climb started on 
Wednesday and continued yesterday, when MSLP added the next 21.88% to its price. At the same time, its traded volume exceeded 16 million shares for the day.
According to the records, the gain should have started this Monday, when MSLP was promoted by Hotstockcafe.com, in order to pump up its stock price. Along with the campaign, Muscle Pharm announced that it has been nominated for the upcoming 2011 Bodybuilding.com supplement awards, though the stock price did not move up. Apparently, the positive alerts worked a bit later and MSLP got the climb a couple of days later.
So far, so good. However, there is another issue facing MSLP now. Last week, the company announced a $1.55 million three-year endorsement deal with the superstar Mike Vick, however, this week it appeared that the sportsman has had another deal with other company. According to the US newspaper The Republic, Mr. Vick has chosen MSLP in the end, though it is interesting what will happen if a third company steps forward.[BANNER]
Muscle Pharm Corp. is a development-stage company that manufactures and markets sports nutrition products. On July 14, the company reported its preliminary financial results for the first quarter ended June 30, this year. According to these, MSLP expects an unaudited gross revenues of approximately $4 million against a net loss that was not listed.
At the same time, the last 10-Q filed with the SEC is not as bright as the latest projections of MSLP. On the contrary, as of end-March, this year the company’s current liabilities were 50% higher than its current assets, and the stockholders’ deficit got over $2 million, apart from the other substantial losses.
Despite the agreements Muscle Pharm has announced lately, there is one question that must be a red signal for investors. Namely, has MSLP managed to turn into a profitable company so fast after all these losses incurred?
